Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: TriClip Japan Post-Approval Study

View source ↗

Summary

Post-approval study in Japan evaluating TriClip for Tricuspid Regurgitation. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TriClip

Snippet

Sponsor: Abbott Medical Devices | Conditions: Tricuspid Regurgitation | Status: RECRUITING